Viatris EBIT 2010-2024 | VTRS

Viatris annual and quarterly EBIT history from 2010 to 2024. EBIT can be defined as earnings before interest and taxes.
  • Viatris EBIT for the quarter ending September 30, 2024 was $0.226B, a 49.99% decline year-over-year.
  • Viatris EBIT for the twelve months ending September 30, 2024 was $-0.265B, a 125.96% decline year-over-year.
  • Viatris 2023 annual EBIT was $0.766B, a 52.55% decline from 2022.
  • Viatris 2022 annual EBIT was $1.615B, a 4849.98% decline from 2021.
  • Viatris 2021 annual EBIT was $-0.034B, a 83.87% decline from 2020.
Viatris Annual EBIT
(Millions of US $)
2023 $766
2022 $1,615
2021 $-34
2020 $-211
2019 $716
2018 $906
2017 $1,437
2016 $699
2015 $1,461
2014 $1,353
2013 $1,136
2012 $1,109
2011 $1,005
2010 $722
2009 $523
Viatris Quarterly EBIT
(Millions of US $)
2024-09-30 $226
2024-06-30 $-240
2024-03-31 $204
2023-12-31 $-454
2023-09-30 $452
2023-06-30 $369
2023-03-31 $400
2022-12-31 $-201
2022-09-30 $560
2022-06-30 $549
2022-03-31 $707
2021-12-31 $-78
2021-09-30 $358
2021-06-30 $-48
2021-03-31 $-266
2020-12-31 $-881
2020-09-30 $351
2020-06-30 $134
2020-03-31 $185
2019-12-31 $272
2019-09-30 $324
2019-06-30 $96
2019-03-31 $24
2018-12-31 $233
2018-09-30 $338
2018-06-30 $179
2018-03-31 $156
2017-12-31 $419
2017-09-30 $317
2017-06-30 $474
2017-03-31 $228
2016-12-31 $313
2016-09-30 $-131
2016-06-30 $411
2016-03-31 $106
2015-12-31 $424
2015-09-30 $601
2015-06-30 $277
2015-03-31 $159
2014-12-31 $393
2014-09-30 $495
2014-06-30 $226
2014-03-31 $239
2013-12-31 $273
2013-09-30 $340
2013-06-30 $309
2013-03-31 $214
2012-12-31 $263
2012-09-30 $335
2012-06-30 $261
2012-03-31 $251
2011-12-31 $247
2011-09-30 $266
2011-06-30 $280
2011-03-31 $212
2010-12-31 $94
2010-09-30 $234
2010-06-30 $195
2010-03-31 $199
2009-12-31 $60
2009-09-30 $61
2009-06-30 $175
2009-03-31 $227
Sector Industry Market Cap Revenue
Medical Medical Services $15.624B $15.427B
Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor and Viagra. Biosimilars portfolio include pegfilgrastim, trastuzumab and adalimumab biosimilars. It has obtained approval for the biosimilar of Avastin and Insulin Aspart in Europe. The company reports in following segments: Developed Markets, Greater China, JANZ & Emerging Markets. The Developed Markets segment comprises operations in N. America and Europe. The Greater China segment operates in China, Taiwan and Hong Kong. The JANZ segment will report for operations in Japan, Australia and New Zealand, while the Emerging Markets segment will include operations in Asia, the Middle East, South and Central America, Africa and E. Europe. This segment also includes the company's anti-retroviral franchise.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $98.658B 12.24
Cencora (COR) United States $49.082B 18.10
DiDi Global (DIDIY) China $23.427B 0.00
ICON (ICLR) Ireland $17.504B 15.59
Natera (NTRA) United States $16.570B 0.00
Avantor (AVTR) United States $15.178B 22.75
Revvity (RVTY) United States $14.682B 25.50
BioMerieux (BMXMF) France $13.087B 0.00
CochLear (CHEOY) Australia $12.998B 0.00
Solventum (SOLV) United States $12.357B 0.00
Doximity (DOCS) United States $11.372B 67.31
Medpace Holdings (MEDP) United States $11.301B 31.84
Charles River Laboratories (CRL) United States $11.285B 21.81
HealthEquity (HQY) United States $8.756B 47.52
Sonic Healthcare (SKHHY) Australia $8.590B 0.00
Bausch + Lomb (BLCO) Canada $7.202B 33.53
Life Times (LTH) United States $5.139B 34.01
Sotera Health (SHC) United States $4.509B 24.12
Organon (OGN) United States $4.144B 4.18
Surgery Partners (SGRY) United States $3.996B 44.27
BrightSpring Health Services (BTSG) United States $3.489B 74.22
PACS (PACS) United States $3.347B 0.00
Alignment Healthcare (ALHC) United States $2.580B 0.00
Concentras Parent (CON) United States $2.505B 0.00
Ardent Health Partners (ARDT) United States $2.471B 0.00
Premier (PINC) United States $2.314B 11.55
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $2.016B 0.00
GoodRx Holdings (GDRX) United States $1.856B 48.90
Teladoc Health (TDOC) United States $1.689B 0.00
Progyny (PGNY) United States $1.540B 27.08
Pediatrix Medical (MD) United States $1.371B 13.41
Establishment Labs Holdings (ESTA) $1.266B 0.00
CareDx (CDNA) United States $1.252B 0.00
AMN Healthcare Services Inc (AMN) United States $1.058B 7.16
Embecta (EMBC) United States $0.910B 6.07
Agilon Health (AGL) United States $0.890B 0.00
InnovAge Holding (INNV) United States $0.809B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.723B 0.00
Auna S.A (AUNA) Luxembourg $0.516B 0.00
Sonida Senior Living (SNDA) United States $0.459B 0.00
DocGo (DCGO) United States $0.411B 15.46
Enhabit (EHAB) United States $0.403B 34.83
COMPASS Pathways (CMPS) United Kingdom $0.363B 0.00
LifeMD (LFMD) United States $0.308B 0.00
Sera Prognostics (SERA) United States $0.248B 0.00
ModivCare (MODV) United States $0.231B 12.54
Beauty Health (SKIN) United States $0.218B 0.00
Biodesix (BDSX) United States $0.205B 0.00
Nutex Health (NUTX) United States $0.152B 0.00
MultiPlan (MPLN) United States $0.137B 0.00
Ascend Wellness Holdings (AAWH) United States $0.107B 0.00
So-Young (SY) China $0.088B 21.28
Singular Genomics Systems (OMIC) United States $0.057B 0.00
Harvard Apparatus Regenerative Technology (HRGN) United States $0.054B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.042B 1.10
Co-Diagnostics (CODX) United States $0.038B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.028B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.020B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00